dc.contributor.author | Kesiime, Christine | |
dc.date.accessioned | 2023-01-25T09:34:50Z | |
dc.date.available | 2023-01-25T09:34:50Z | |
dc.date.issued | 2022-12-22 | |
dc.identifier.citation | Kesiime, C. (2022). Parasite load and plasma cytokine levels in Trypanosoma Brucei infected rats administered with systemic IL-6 AND IL-10. (Unpublished Master's Dissertation). Makerere University, Kampala, Uganda. | en_US |
dc.identifier.uri | http://hdl.handle.net/10570/11704 | |
dc.description | A dissertation submitted to the Directorate of Research and Graduate Training in partial fulfillment of the requirements for the award of the degree of Master of Science in Molecular Biology and Biotechnology of Makerere University. | en_US |
dc.description.abstract | The invasion of central nervous system (CNS) by trypanosomes is mediated by
cytokine modulations and responses. The pro-inflammatory cytokine response
facilitates the progression to the late stage while the anti-inflammatory cytokine
responses hinder this progression. The study assessed parasite load and selected plasma
cytokine levels in Trypanosoma brucei brucei infected rats administered with systemic
IL-6 and IL-10 for novel therapeutic agent development. Wister albino rats were
infected with Trypanosoma brucei brucei GVR35 and then administered with IL-6, IL-
10 or combined IL-6 and IL-10 on day 11 post-infection. Monitoring of blood
trypanosome density from day 11-17 post-infection was by microscopy. Trypanosome
density in CNS was determined by real-time quantitative PCR for trypanosome Pfr2
gene copies. Plasma cytokine levels were measured by sandwich Enzyme-Linked
Immuno Sorbent Assay. Data was statistically analysed using Graphpad Prism 8.0 at
p<0.05 significance. There was significant variation in blood parasite density across
treatment groups post-infection (p=0.047). A significant difference between
Diminazene aceturate and IL-10 mono-treatment groups in blood parasite density
(p=0.001) was observed. However, no significant variation in blood parasite density
when Diminazene aceturate treatment was compared to IL-6 mono-treatment and IL-
6/IL-10 combination treatment groups (p=0.225). There was a significant difference
observed in rat survival across treatment groups (p=0.0001). The results showed significant
variation of CNS trypanosome Pfr2 copies across treatment groups at p<0.05. The study
demonstrated that systemic administration of the anti-inflammatory cytokines IL-6
or/and IL-10 significantly reduced CNS parasitosis. Administration of IL-6 or IL-6/IL-
10 combination significantly down-regulated plasma IFN-γ and TNF-α levels (p<0.05).
However, there was no significant reduction in plasma IFN-γ and TNF-α levels in IL-
10 treatment as compared to untreated infected rats. There was no significant difference
in plasma IL-6 and IL-10 levels among the different treatments observed. Therefore,
CNS invasion and survival of parasites may be susceptible to immunological
modulation. | en_US |
dc.description.sponsorship | Consortium for Advanced Research Training in Africa (CARTA) and Government of Uganda through the Research Innovation Fund at Makerere University (RIF1/COVAB/008) | en_US |
dc.language.iso | en | en_US |
dc.publisher | Makerere University | en_US |
dc.subject | parasite load | en_US |
dc.subject | cytokines | en_US |
dc.subject | trypanosomes | en_US |
dc.subject | Trypanosoma Brucei | en_US |
dc.subject | rats | en_US |
dc.subject | systemic IL-6 and IL-10 | en_US |
dc.title | Parasite load and plasma cytokine levels in Trypanosoma Brucei infected rats administered with systemic IL-6 AND IL-10 | en_US |
dc.type | Thesis | en_US |